This study looks at two versions of a drug called tacrolimus, which helps prevent the body from rejecting a new kidney. It focuses on African American kidney transplant recipients to see if taking the drug once a day (extended release) is better for blood vessel health than takin…
Phase: PHASE4 • Sponsor: Roy D. Bloom, MD • Aim: Disease control
Last updated May 11, 2026 20:37 UTC